GenoScreen™ SARS-CoV-2 RT-qPCR Assay received 100% concordance results in the latest HKSAR Department of Health QAP (March 2021 Program)

29 March 2021 [Comunicado de prensa]

GenoScreen™ SARS-CoV-2 RT-qPCR Assay received 100% concordance results in the latest HKSAR Department of Health QAP (March 2021 Program)

The GenoScreen^TM SARS-CoV-2 RT-qPCR Assay again delivered a 100% concordance outcome in the HKSAR Department of Health’s latest SARS-CoV-2 Quality Assurance Program.

The samples included in this SARS-CoV-2 Quality Assurance Programme were prepared by Public Health Laboratory Services Branch, Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region Government. The samples are frozen transport medium samples with or without inactivated SARS-CoV-2 (whole virus).

Please visit our product page or contact us directly if you would like to learn more.

Acerca de DiagCor

Ubicados en Hong Kong, DiagCor se ha dedicado al desarrollo de pruebas moleculares (MDx) desde el 2006. Como líderes mundiales de la tecnología de hibridación rápida (flow-through hybridization), nuestra compañía ofrece una amplia gama de productos, soluciones y servicios relacionados con el análisis de ADN y ARN. Así mismo proveemos servicios de laboratorio MDx a médicos y profesionales en Asia Pacífica. DiagCor desarrolla y fabrica productos y soluciones MDx y a su vez ofrece consultoría en medicina translacional para proyectos MDx.

Contacto de prensa

DiagCor Life Science

[email protected]